ZA200404444B - A process for the preparation of a non-toxic anthrax vaccine - Google Patents
A process for the preparation of a non-toxic anthrax vaccineInfo
- Publication number
- ZA200404444B ZA200404444B ZA200404444A ZA200404444A ZA200404444B ZA 200404444 B ZA200404444 B ZA 200404444B ZA 200404444 A ZA200404444 A ZA 200404444A ZA 200404444 A ZA200404444 A ZA 200404444A ZA 200404444 B ZA200404444 B ZA 200404444B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- anthrax vaccine
- toxic
- toxic anthrax
- vaccine
- Prior art date
Links
- 241000193738 Bacillus anthracis Species 0.000 title 1
- 231100000252 nontoxic Toxicity 0.000 title 1
- 230000003000 nontoxic effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1222DE2001 | 2001-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200404444B true ZA200404444B (en) | 2006-03-29 |
Family
ID=11097141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200404444A ZA200404444B (en) | 2001-12-05 | 2004-06-04 | A process for the preparation of a non-toxic anthrax vaccine |
Country Status (12)
Country | Link |
---|---|
US (1) | US7888490B2 (zh) |
EP (2) | EP1958960A3 (zh) |
JP (1) | JP2005511059A (zh) |
CN (1) | CN1694722A (zh) |
AU (1) | AU2002242935A1 (zh) |
BR (1) | BRPI0215039A2 (zh) |
CA (1) | CA2469671A1 (zh) |
IL (1) | IL162381A0 (zh) |
MX (1) | MXPA04005538A (zh) |
RU (1) | RU2287581C2 (zh) |
WO (1) | WO2003048390A1 (zh) |
ZA (1) | ZA200404444B (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8481043B2 (en) * | 2001-06-22 | 2013-07-09 | Cpex Pharmaceuticals, Inc. | Nasal immunization |
US20060246079A1 (en) * | 2003-11-14 | 2006-11-02 | Morrow Phillip R | Neutralizing human antibodies to anthrax toxin |
WO2005081749A2 (en) * | 2004-01-23 | 2005-09-09 | Avanir Pharmaceuticals, Inc. | Neutralizing human antibodies to anthraxtoxin |
US8409590B2 (en) | 2004-02-11 | 2013-04-02 | Ligocyte Pharmaceuticals, Inc. | Anthrax antigens and methods of use |
EP1954307A4 (en) * | 2005-11-14 | 2009-12-02 | Univ Maryland Biotech Inst | ORAL VACCINES AGAINST MILZBRAND ON SALMONELLA BASE |
CN100362094C (zh) * | 2006-02-14 | 2008-01-16 | 中国人民解放军军事医学科学院生物工程研究所 | 一株无pX01和pX02质粒的炭疽杆菌菌株及其用途 |
GB0607462D0 (en) * | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
CA2651962A1 (en) * | 2006-05-12 | 2007-12-21 | Oklahoma Medical Research Foundation | Anthrax compositions and methods of use and production |
WO2008152655A1 (en) * | 2007-06-11 | 2008-12-18 | Panacea Biotec Limited Limited | Anthrax fusion proteins, compositions and uses thereof |
WO2008152654A1 (en) * | 2007-06-11 | 2008-12-18 | Panacea Biotec Limited | Anthrax fusion proteins, compositions and uses thereof |
CA2738621C (en) | 2008-10-02 | 2017-01-31 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
CN101798565B (zh) * | 2010-02-26 | 2013-08-07 | 中国人民解放军军事医学科学院生物工程研究所 | 能在芽孢表面展示pa20蛋白的炭疽芽孢杆菌及其应用 |
WO2012171329A1 (zh) * | 2011-06-15 | 2012-12-20 | Du Quan | 一种核酸分离的方法及其应用 |
CN102516394B (zh) * | 2011-12-14 | 2014-07-09 | 中国人民解放军军事医学科学院生物工程研究所 | CMG2突变体和Fc的融合蛋白及其编码基因与应用 |
CN105749265B (zh) * | 2016-03-30 | 2020-03-27 | 中国疾病预防控制中心传染病预防控制所 | 一种二价炭疽疫苗 |
CN105797148B (zh) * | 2016-03-30 | 2020-01-14 | 中国疾病预防控制中心传染病预防控制所 | 一种无毒炭疽活疫苗及无毒炭疽菌株 |
CA3165957A1 (en) | 2020-01-24 | 2021-07-29 | Thomas K. EQUELS | Methods, compositions, and vaccines for treating a virus infection |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2017606A (en) | 1932-12-24 | 1935-10-15 | Sharp & Dohme Inc | Anthrax antigen preparation and product |
US2151364A (en) | 1937-06-02 | 1939-03-21 | Cutter Lab | Anthrax vaccine |
RU2115433C1 (ru) | 1992-08-28 | 1998-07-20 | Научно-исследовательский институт микробиологии МО РФ | Вакцина сибиреязвенная комбинированная |
DE69940157D1 (en) | 1998-07-10 | 2009-02-05 | U S Medical Res Inst Of Infect | Anthrax-impfstoff |
FR2798291B1 (fr) * | 1999-09-10 | 2005-01-14 | Pasteur Institut | Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis |
US20020051791A1 (en) * | 1999-12-22 | 2002-05-02 | Galloway Darrel R. | Methods for protection against lethal infection with bacillus anthracis |
WO2001082788A2 (en) * | 2000-05-04 | 2001-11-08 | President And Fellows Of Harvard College | Compounds and methods for the treatment and prevention of bacterial infection |
WO2002100340A2 (en) * | 2001-06-08 | 2002-12-19 | Avant Immunotherapeutics, Inc. | Improved vaccination against anthrax |
GB0116798D0 (en) * | 2001-07-10 | 2001-08-29 | Secr Defence | Expression system |
GB0126266D0 (en) * | 2001-11-01 | 2002-01-02 | Microbiological Res Authority | Anthrax antigenic compositions |
-
2002
- 2002-03-20 EP EP08006580A patent/EP1958960A3/en not_active Withdrawn
- 2002-03-20 JP JP2003549567A patent/JP2005511059A/ja active Pending
- 2002-03-20 IL IL16238102A patent/IL162381A0/xx unknown
- 2002-03-20 CA CA002469671A patent/CA2469671A1/en not_active Abandoned
- 2002-03-20 AU AU2002242935A patent/AU2002242935A1/en not_active Abandoned
- 2002-03-20 WO PCT/IN2002/000048 patent/WO2003048390A1/en active Application Filing
- 2002-03-20 BR BRPI0215039A patent/BRPI0215039A2/pt not_active IP Right Cessation
- 2002-03-20 MX MXPA04005538A patent/MXPA04005538A/es not_active Application Discontinuation
- 2002-03-20 EP EP02708609A patent/EP1453534A1/en not_active Withdrawn
- 2002-03-20 CN CNA028277724A patent/CN1694722A/zh active Pending
- 2002-03-20 RU RU2004120293/13A patent/RU2287581C2/ru not_active IP Right Cessation
- 2002-03-20 US US10/497,673 patent/US7888490B2/en not_active Expired - Fee Related
-
2004
- 2004-06-04 ZA ZA200404444A patent/ZA200404444B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US7888490B2 (en) | 2011-02-15 |
CN1694722A (zh) | 2005-11-09 |
RU2287581C2 (ru) | 2006-11-20 |
MXPA04005538A (es) | 2005-06-08 |
WO2003048390A8 (en) | 2004-02-05 |
EP1958960A2 (en) | 2008-08-20 |
JP2005511059A (ja) | 2005-04-28 |
AU2002242935A8 (en) | 2003-06-17 |
IL162381A0 (en) | 2005-11-20 |
US20050063986A1 (en) | 2005-03-24 |
EP1958960A3 (en) | 2009-01-07 |
WO2003048390A1 (en) | 2003-06-12 |
RU2004120293A (ru) | 2005-04-20 |
BRPI0215039A2 (pt) | 2016-06-28 |
AU2002242935A1 (en) | 2003-06-17 |
EP1453534A1 (en) | 2004-09-08 |
CA2469671A1 (en) | 2003-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1067891A1 (en) | Influenza vaccine composition | |
HK1168792A1 (zh) | 阿立哌唑口服溶液 | |
AU2002353378A8 (en) | Vaccine for periodontal disease | |
AU2002242935A8 (en) | A process for the preparation of a non-toxic anthrax vaccine | |
HUP0402471A3 (en) | Vaccine | |
GB0407935D0 (en) | Vaccine | |
HUP0402027A3 (en) | Process for the preparation of a xantophyll | |
IL157498A0 (en) | Vaccine | |
EP1423141A4 (en) | VACCINE | |
GB0306611D0 (en) | Novel vaccine | |
GB2393122B (en) | Improved vaccination against anthrax | |
GB0121171D0 (en) | Vaccine | |
IL143106A (en) | Process for the preparation of diphenylmethylthioacetamide | |
IL160193A0 (en) | Process for the preparation of a 14-hydroxynormorphinone derivative | |
HUP0201837A3 (en) | Process for preparation n-carboxy-anhydrides | |
EP1429615A4 (en) | ORAL VACCINES | |
HUP0303025A3 (en) | Process for the preparation of arylethanoldiamines | |
PL368905A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
HU0204443D0 (en) | Process for preparing fluoroformates | |
GB0123828D0 (en) | Vaccine production | |
GB0129338D0 (en) | Vaccination | |
HUP0401165A3 (en) | Process for the preparation of 5-formylphtalide | |
GB0113667D0 (en) | Process for the preparation of endo-5-norbornene-2-ol | |
HRP20010190B1 (en) | Process for the preparation of alpha-arbutine | |
GB0128312D0 (en) | Vaccine |